A novelly designed protein antagonist confers potent neutralization against SARS-COV-2 variants of concern. Lv P, Hu B, Hua R, Zhang J, et al. J Infect 2022 Jun 3. pii: S0163-4453(22)00350.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lv P, Hu B, Hua R, Zhang J, et al. A novelly designed protein antagonist confers potent neutralization against SARS-COV-2 variants of concern. J Infect 2022 Jun 3. pii: S0163-4453(22)00350.
PMID: 35667483